
---
title: '针对Omicron疫苗开发中 辉瑞CEO：最快3月问世'
categories: 
 - 新媒体
 - 快媒体
 - 首页更新
headimg: 'https://www.kuai.media/news/2022/01/11/static/image/kuai/external-link.gif'
author: 快媒体
comments: false
date: 2022-01-11 05:10:11
thumbnail: 'https://www.kuai.media/news/2022/01/11/static/image/kuai/external-link.gif'
---

<div>   
<a href="https://www.kuai.media/go.php?aid=328500" target="_blank" role="link" data-focusable="true" class="sum" rel=" noopener noreferrer">

<strong>摘要</strong>: Pfizer Inc Chief Executive Albert Bourla said on Monday that moving toward a redesigned COVID-19 vaccine that is specifically targeted to combat the Omicron variant of the coronavirus is the most likely scenario. https://t.co/uaZUWHz1Y9mdash; Reuters Health (@Reuters_Health) January 10, 2022美国辉瑞（Pfizer）执行长博尔拉 （Albert Bourla）指出，要应对Omicron变种毒株，需要一种重新设计的疫苗，他表示，辉瑞应可在3月底前推出一款针对Omicron的疫苗。据《路透》报导，博尔拉在当地时间週一（1月10日）于摩根大通的年度医疗保健会议上透露，辉瑞公司与其德国合作伙伴BioNTech正在开发一种专门针对Omicron的疫 ... <span class="more"><img width="35" src="https://www.kuai.media/news/2022/01/11/static/image/kuai/external-link.gif" referrerpolicy="no-referrer">点击阅读全文 @ltn.com.tw</span>
</a>


  
</div>
            